InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Aggarwal Gaurav, Director. Officer active across 4 companies, notably Sierra Oncology, Inc.. Aggregated, 9 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €19.4m. Activity tracked since 26 January 2022. The latest transaction was disclosed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Gaurav Aggarwal is Administrateur. He has 9 filings in total, and in the recent filings available, the aggregated amounts show EUR 19368072 of buys and EUR 143611897 of sells, over a period from 2016-01-19 to 2025-08-26. He is linked to Unicycive Therapeutics, Inc., Sierra Oncology, Inc., GERON CORP and Ocera Therapeutics, Inc.